CbsBioscience   Report issue

For profit Phase 2
Founded: Yuseong-gu Korea, Republic of (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2016
NCT02967887
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now